What Makes GPR55 an Emerging Key Player in the ECS The endocannabinoid system (ECS) has long been defined by its two primary receptors, CB1 and CB2, which mediate a wide range of physiological …
Read More about GPR55: A New Cannabinoid Receptor with Big Potential? →
Unlocking Novel Treatments Imagine a scenario where a patient with chronic migraines uses a CBD spray combined with a low-dose nitric oxide (NO) nasal spray, achieving faster, longer-lasting pain …
Simple Strategies That May Lower Chronic Disease Risk Mounting research suggests that your body’s pH isn’t just a matter of digestion or hydration—it plays a foundational role in your long-term …
Read More about pH and the Endocannabinoid System: A New Path to Resilience? →
As cannabis medicine becomes more nuanced, so too does our understanding of how cannabinoids interact with the classical endocannabinoid system (ECS) and the larger environment defined as the …
Read More about The Future of Cannabinoid Therapy Is Light-Activated and Precision-Tuned →
Ketamine and the EndocannabinoidomeRevolutionizing Mental Health Treatment with New Insights Ketamine, developed in the early 1960s as a "safer" alternative to phencyclidine (PCP), is a …
Psilocybin and the EndocannabinoidomeExploring Breakthroughs in Mental Health Treatment Psilocybin, a naturally occurring tryptamine alkaloid found in various species of fungi commonly known as …
